Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-20

Clinical Trial Update: A Study of Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE)

View source ↗

Summary

This clinical trial update reports on lanadelumab being studied in teenagers and adults with hereditary angioedema; the study is currently active but not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Takhzyro (lanadelumab)

Snippet

Sponsor: Takeda | Conditions: Hereditary Angioedema (HAE) | Status: ACTIVE_NOT_RECRUITING